Skip to main content

2 March 2026

Last updated: Sunday 1 March 2026

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

Genmab looks ahead to next phase of growth

Sunday 11 November 2018

Interviewee/Contributor

Jan van de Winkel

Organisation

Genmab A/S

Why industry is investing in bispecific molecules

Wednesday 15 June 2016

Interviewee/Contributor

Jan van de Winkel

Organisation

Genmab A/S

Organisations

Jon Rees Associates
Bicycle Therapeutics Ltd
ICON P&MA
Merck Sharp & Dohme (Europe)
[email protected]
Howrey LLP
Orchard Therapeutics
US National Cancer Institute
European Patent Office
IP Group

Interviewees and Contributers

Stefan Larsson
Graeme Martin
Ali Mortazavi
Gerhard Müller
Robert Burns
Helen Boucher
Karol Sikora
Jonathan Frampton
Todd McAllister
Jytte Lyngvig

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

VoxCell appoints CCO

Saturday 28 February 2026

Qlaris Bio appoints board director

Saturday 28 February 2026

Clarametyx adds four experts to SAB

Saturday 28 February 2026

Enhanced Genomics appoints Katerina Leftheris to board

Saturday 28 February 2026

New COO at Qureight

Saturday 28 February 2026

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2026 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form